Medartis Holding AG

Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%

Basel, 9th July 2024   Matthias Schupp appointed as CEO of Medartis

Basel, 11th June 2024   Medartis announces resignation of CEO Christoph Brönnimann

Medartis successfully places CHF 115.8 million convertible bonds due 2031

Medartis launches senior convertible bond offering in a private placement of approximately CHF 115 million due 2031

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16%

Medartis on track with 16% internal growth after 6 months

Medartis 2023 half-year results presentation

Medartis shareholders approve all proposals at the AGM 2023

Medartis announces completion of a CHF 30 million capital increase to finance its additional stake in Keri Medical

Medartis increases revenue by 18% (CER) to CHF 183 million and continues to invest in future growth

Medartis 2022 full-year results presentation

Medartis reports 20% sales growth and makes further progress in strengthening its US organisation

Medartis completes acquisition of Nextremity Solutions Inc. and announces new US leadership

Medartis has decided not to pursue the convertible bond placement

Medartis launches senior convertible bond offering with a target size of CHF 125-150 million

Medartis shareholders approve all proposals of the Board of Directors

Strong sales growth and further margin improvements – important acquisition to accelerate the US extremities business

Medartis accelerates sales growth to 29% in H1 2021 and improves profitability

Medartis überreicht Spende an die regionale Stiftung Pro UKBB

Medartis Holding AG : Annual General Meeting approves all proposals of the Board of Directors and elects Marco Gadola as the new Chairman of the Board of Directors

Medartis Holding AG: Medartis achieves solid full-year 2020 result and nominates new Chairman of the Board of Directors for election

Medartis Holding AG | Invitation Media and Investor conference | 2020 annual results

Medartis appoints Dirk Kirsten as Chief Financial Officer and EMB member

Medartis announces strategic partnership with KeriMedical

Medartis Holding AG : Press release 2020 half-year results and change in Executive Management Board

Medartis appoints Mareike Loch as Vice President EMEA and EMB Member

Medartis appoints Lisa Thompson as Member of the Executive Management Board and President North America

Medartis nominates Marco Gadola for election to the Board of Directors

Medartis reports good sales growth above market levels in 2019